Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus.
Serena FasanoValentina MessinitiMichele IudiciMelania Alessia CosciaFrancesco CicciaPublished in: Lupus science & medicine (2023)
Patients with low oral HCQ dosage tend to have more flares, although the difference was not statistically significant. Higher HCQ blood levels were protective against flare occurrence. The risks and benefits must be balanced in choosing HCQ dose.